|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2009-1-27
|
|
pubmed:abstractText |
Carboplatin dosing based on renal function and therapeutic monitoring have been previously shown to be beneficial in the treatment of children with cancer. However, the applicability of such approaches to the treatment of premature or newborn infants, where kidney function may change markedly with advancing gestational and postnatal age, is unknown. Diagnosis of retinoblastoma in a preterm infant provided a rare opportunity to carry out adaptive carboplatin dosing in a patient with immature renal function.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1432-0843
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
63
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
749-52
|
|
pubmed:meshHeading |
pubmed-meshheading:18607591-Antineoplastic Agents,
pubmed-meshheading:18607591-Area Under Curve,
pubmed-meshheading:18607591-Carboplatin,
pubmed-meshheading:18607591-Dose-Response Relationship, Drug,
pubmed-meshheading:18607591-Drug Monitoring,
pubmed-meshheading:18607591-Female,
pubmed-meshheading:18607591-Gestational Age,
pubmed-meshheading:18607591-Humans,
pubmed-meshheading:18607591-Infant, Newborn,
pubmed-meshheading:18607591-Infant, Premature,
pubmed-meshheading:18607591-Kidney Function Tests,
pubmed-meshheading:18607591-Metabolic Clearance Rate,
pubmed-meshheading:18607591-Retinal Neoplasms,
pubmed-meshheading:18607591-Retinoblastoma,
pubmed-meshheading:18607591-Tissue Distribution,
pubmed-meshheading:18607591-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Therapeutic monitoring of carboplatin dosing in a premature infant with retinoblastoma.
|
|
pubmed:affiliation |
Paediatric Oncology Unit, St James's Hospital, Leeds, UK.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
